Cathy L. Burgess

Unauthorized H1N1 Product Claims Targeted by Federal Agencies
Cathy L. Burgess, James C. Chen, Jennifer Gruda Knight, Jennifer E. Schlosser, November 25, 2009
In the wake of the worldwide 2009 H1N1 pandemic, federal agencies are closely scrutinizing statements in advertisements and on labels that claim products are effective against the H1N1 flu virus. Makers of a host of products - from drugs and medical devices to dietary supplements and household...

Congress Moving Quickly On Food Safety Legislation
Cathy L. Burgess, Kristina M. Pisanelli, Steven Niedelman, June 24, 2009
On June 3, 2009, the House Energy and Commerce Subcommittee on Health held a hearing on the discussion draft of the Food Safety Enhancement Act of 2009, legislation that would grant the Food and Drug Administration ("FDA") new authority and resources to regulate the nation's food supply.

Wyeth v. Levine: U.S. Supreme Court Rules FDA Approval of Label Does Not Provide Pharmaceutical Manufacturer with Complete Preemption Defense to State Failure-to-Warn Claims
Karen A. Gibbs, Heather L. Hodges, Cathy L. Burgess, March 25, 2009
In Wyeth v. Levine, the Plaintiff Diana Levine claimed she was injured by the inappropriate administration of Wyeth's prescription drug Phenergan.